uBriGene Biosciences

uBriGene is a premier Biotechnology company dedicated to advancing the field of cell and gene therapy through innovative contract development and manufacturing organization (CDMO) services. Headquartered in Maryland, USA, uBriGene operates across North America and Asia, bridging the gap from advanced therapy medicinal products (ATMPs) concepts to commercialization. Our expert team excels in the research and development (R&D), manufacturing, and testing of viral vectors, cell therapies, and other ATMP modalities, ensuring that projects receive unparalleled support at every developmental stage.

Our mission is clear: to streamline the complexities of bringing advanced therapies to market by providing tailored services that meet client needs effectively. With a strong focus on quality, we utilize state-of-the-art technology platforms, optimizing production processes while adhering to the highest industry standards. With over 20 INDs successfully filed and accepted by global regulatory bodies, our commitment to excellence is evident in every service we provide. At uBriGene, we are committed to improving patient lives by making remarkable therapies accessible and efficient.